Cytokine-induced signal transduction is executed by natural biological switches, which among many others control immune-related processes. Here, we show that synthetic cytokine receptors (SyCyRs) can induce cytokine signaling using non-physiological ligands. Highaffinity GFP-and mCherry-nanobodies were fused to transmembrane and intracellular domains of the IL-6/IL-11 and IL-23 cytokine receptors gp130 and IL-12Rβ1/IL-23R, respectively. Homo-and heterodimeric GFP:mCherry fusion proteins as synthetic cytokine-like ligands were able to induce canonical signaling in vitro and in vivo. Using SyCyR ligands, we show that IL-23 receptor homodimerization results in its activation and IL-23-like signal transduction. Moreover, trimeric receptor assembly induces trans-phosphorylation among cytokine receptors with associated Janus kinases. The SyCyR technology allows biochemical analyses of transmembrane receptor signaling in vitro and in vivo, cell-specific activation through SyCyR ligands using transgenic animals and possible therapeutic regimes involving non-physiological targets during immunotherapy.
S ynthetic biology deconstructs and reassembles biological bits and pieces to construct biological devices for applications such as biological sensors, releasers, and switches 1 . Cytokine-induced signal transduction is executed by natural biological switches among many other functions control immune-related processes 2 . In principle, cytokine receptors are in an off-state in the absence of cytokines and in an on-state in the presence of cytokines. The on-state might be interrupted by negative feedback mechanisms or depletion of the cytokine and cytokine receptor. In the past, we reported ligand-independent synthetic receptors based on fusions of leucine zippers or IL-15/ sushi and the IL-6-signal transducer gp130, which are locked in the on-state, but were not switchable 3, 4 . Interestingly, a marked activation of IL-6/IL-11 signaling in inflammatory hepatocellular adenomas was directly caused by gain-of-function mutations within the gp130-receptor chain, leading to ligandindependent constitutively active gp130 receptors 5 . Others described switchable synthetic cytokine receptors, resulting in gp130-induced signaling by stimulation with the cytokine erythropoietin (EPO) 6 . The major drawback of this system was that EPO has cross-reactivity with its natural EPO-receptors limiting its applications both in vitro and in vivo. Also, higher ordered multi-receptor complexes cannot be assembled using natural ligands such as EPO, which only induces receptorhomodimerization. Direct intracellular activation of signal transduction and induction of cell death was achieved using cell permeable, synthetic ligands (FK506), and binding proteins (FKBP12) resulting in homodimerization and homooligomerization 7, 8 . The extent of oligomerization was, however, not controllable. Various formats of synthetic transmembrane receptors have been designed to optimize engineered chimeric antigen receptor (CAR) T-cell responses, including costimulatory receptors [9] [10] [11] , notch-based receptors 12 , and antigen-specific inhibitory receptors 13 . However, a switchable and background-free synthetic cytokine receptor system with full control over the assembly modus of the receptor complexes, e.g., hetero/homodimeric, -trimeric, or -multimeric is not available. Such a specific system would be a valuable tool to study receptor activation, their kinetics, stoichiometry, and biochemical properties. Moreover, background-free activation of cytokine receptors opens a great potential for novel therapeutic regimes involving non-physiological ligands during immunotherapy. Recently developed nanobodies specifically recognizing GFP and mCherry fail to bind endogenous ligands 14, 15 and thus qualify as binding partners of synthetic cytokine receptors. The N-terminal region of Camelidae heavychain antibodies contains a dedicated variable domain, referred to as VHH or nanobodies, which binds to its cognate antigen. Nanobodies are single-domain antibodies of about 110 aminoacid residues generated from the variable regions of these heavy-chain antibodies 16 . Here, these nanobodies were used as extracellular sensors for homo-and heteromeric GFP:mCherry fusion proteins as part of Synthetic Cytokine Receptors (SyCyRs), ultimately leading to the formation and activation of homo-and heterodimeric and heterotrimeric receptor complexes. As biological read-out system, we use IL-23-and IL-6/ IL-11-signaling. Consequently, the extracellular sensors were fused to intracellular IL-23-and gp130-receptor chains. Using this set-up, we design a switchable synthetic cytokine receptor system, which resembles IL-23-and IL-6/IL-11-signaling and reveal that homodimeric IL-23R were biologically active. Moreover, we demonstrate that the Janus kinase activity and STAT3 phosphorylation-binding site in the intracellular domain (ICD) of the receptor can be separated on two different receptor chains, a phenomenon, which is referred to as transphosphorylation.
Results
SyCyRs simulate IL-23 and IL-6/IL-11 signaling. Natural biological switches regulate cytokine-induced signal transduction via receptor activation and inactivation. Highly specific nanobodies against GFP and mCherry were selected to mediate sensitive and background-free cytokine-like signaling. Naturally, IL-23 signals via its receptor complex consisting of IL-23R and IL-12Rβ1. To mimic IL-23 signaling, we generated two synthetic cytokine receptors (SyCyRs) in which the extracellular part, including the ligand-binding site of the IL-23R and the IL-12Rβ1 was replaced by nanobodies specifically recognizing mCherry (C VHH ) and GFP (G VHH ), respectively 14, 15 ( Fig. 1a and Supplementary Fig. 1a ). SyCyRs were expressed in Ba/F3-gp130 cells ( Supplementary  Fig. 1b) , which proliferate following STAT3 activation by the fusion protein of IL-6 and soluble IL-6R named Hyper-IL-6 (HIL-6) 17 (Fig. 1b) . As synthetic ligands for SyCyRs, we generated GFP-mCherry fusion proteins and various combinations ( Fig. 1a and Supplementary Figs. 2 and 3 ). Since STAT3 activation is a hallmark of IL-23 signal transduction, we tested if STAT3-dependent proliferation of Ba/F3-gp130 cells expressing C VHH -IL-23R and G VHH -IL-12Rβ1 (Ba/F3-SyCyR(IL-23/2A) generated using 2A-technology with both cDNAs combined in one open reading frame and Ba/F3-SyCyR(IL-23) generated with two separate cDNAs could be induced with GFP and mCherry proteins and fusions of these. Interestingly, proliferation of Ba/F3-SyCyR(IL-23/2A) cells was specifically induced by GFP-mCherry and 2xGFP-mCherry fusion proteins, but not by single GFP and mCherry proteins (Fig. 1b) . Ba/F3 cells only expressing C VHH -IL-23R or G VHH -IL-12Rβ1 failed to proliferate, demonstrating the high selectivity of GFP-mCherry as a synthetic cytokine ligand. Comparative analysis of the dose-dependent proliferation of Ba/ F3-SyCyR(IL-23/2A) and Ba/F3-IL-12Rβ1-IL-23R cells with GFP-mCherry and Hyper-IL-23 (HIL-23), respectively, revealed that the natural cytokine and synthetic cytokine exhibited comparable potency with half-maximal proliferation achieved with HIL-23 (56 kDa) and GFP-mCherry (57 kDa) concentrations of about 5-10 ng/ml (Fig. 1c) . GFP-mCherry-induced cellular proliferation of Ba/F3-SyCyR(IL-23/2A) cells was specifically inhibited by a soluble G VHH -C VHH fusion protein ( Fig. 1d and Supplementary Fig. 4 ). Analysis of intracellular signal transduction showed that the GFP-mCherry, 2xGFP-mCherry fusion proteins, but not single mCherry, GFP and 3xGFP proteins induced JAK, STAT3, ERK1/2, and AKT phosphorylation in Ba/ F3-SyCyR(IL-23/2A) cells (Fig. 1e, f) . SyCyR(IL-23/2A) also resulted in specific STAT3 activation in U4C cells (Fig. 1g) . Kinetics of pSTAT3 and SOCS3 induction following of Ba/F3-SyCyR(IL-23/2A) and Ba/F3-IL-12Rβ1-IL-23R cells with either GFP-mCherry or HIL-23 were comparable (Fig. 2) . Since the IL-23R complex is not targeted by SOCS3, activation resulted in sustained STAT3 phosphorylation 18 . Next, we analyzed the mRNA-expression by gene-array analysis of Ba/F3-SyCyR(IL-23/ 2A) cells stimulated with GFP-mCherry and Ba/F3-IL-12Rβ1-IL-23R cells stimulated with HIL-23. GFP-mCherry and HIL-23 upor downregulated 107 and 193 genes, respectively, by a factor 1.5 or more (Fig. 3a) . Among them are typical STAT3-target genes, including PIM1, SOCS3 and OSM (Fig. 3b, c) . Pathway analysis revealed that the genes regulated by GFP-mCherry and HIL-23 belong to the same pathways ( Fig. 3d and Supplementary Figs. 5-7). Our data revealed a high degree of overlap between the transcriptome induced by the synthetic ligand as compared to the natural cytokine.
To investigate whether SyCyRs can be activated by homodimeric ligands, we adapted this system to the IL-6/IL-11 receptor complex 19 . A SyCyR for gp130 was generated in which the extracellular part of the cytokine receptor was replaced by G VHH (G VHH -gp130) ( Fig. 4a and Supplementary Fig. 1a) . Expression of G VHH -gp130 in Ba/F3-gp130 cells (Ba/F3-SyCyR(IL-6)) was verified by flow cytometry (Supplementary Fig. 1b) . As expected, JAK, TYK, STAT3, ERK1/2 phosphorylation in Ba/F3-SyCyR(IL-6) cells was specifically induced by 2xGFP-mCherry and 3xGFP (Fig. 4b, c) . Comparison of the dose-dependent proliferation of Ba/F3-SyCyR(IL-6) and Ba/F3-gp130 with 3xGFP and HIL-6, respectively, showed that the natural and synthetic cytokine exhibited similar activity with half-maximal proliferation at 1-10 ng/ml 3xGFP (86 kDa) or HIL-6 (60 kDa), respectively (Fig. 4d) .
As depicted in Fig. 4e, 3xGFP -stimulation of Ba/F3-SyCyR(IL-6) cells resulted in time-dependent fast activation and slight inactivation of STAT3 phosphorylation after 120 min, which was accompanied by upregulation of SOCS3. Overall, 3xGFP-induced signal transduction was undistinguishable from HIL-6 induced STAT3 phosphorylation and SOCS3 expression. Next, we expressed SyCyR(IL-6) in liver tissue of C57BL/6 mice. Twenty-four hours after injection of cDNAs coding for G VHHgp130 and 3xGFP alone or in combination, we observed STAT3 phosphorylation when G VHH -gp130 was coexpressed with 3xGFP ( Fig. 4f, g ). Interestingly, G VHH -gp130 expression was found to be much higher in mice injected only with the cDNA coding for G VHH -gp130 as compared to mice expressing both, G VHH -gp130 and 3xGFP. The data suggest that co-expression of G VHH -gp130 and 3xGFP resulted in activation-dependent degradation of G VHH -gp130. Moreover, detection of 3xGFP in serum samples by western blotting showed strong accumulation of 3xGFP in mice injected only with the cDNA coding for 3xGFP, whereas 3xGFP was hardly detectable in mice injected with cDNAs coding for G VHH -gp130 and 3xGFP. These findings suggest that not only G VHH -gp130 but also 3xGFP protein was efficiently internalized and degraded in liver cells after binding and activation of G VHHgp130 (Fig. 4f) . Consistently, expression of the acute phase response gene Saa1 was increased following injection of cDNAs coding for G VHH -gp130 and 3xGFP (Fig. 4h) , in sharp contrast to injection of cDNA coding for G VHH -gp130 or 3xGFP alone. Overall, our data showed that the tested SyCyRs phenocopied IL-6 and IL-23 signaling in vitro and in vivo.
IL-23R-SyCyR homodimers are biologically active. Since multimeric GFP was able to induce IL-6 signal transduction via homodimeric G VHH -gp130, we wondered, whether IL-23R is also biologically active as a homodimer. Accordingly, we created a SyCyR consisting of the extracellular G VHH fused to the transmembrane and intracellular domains of the IL-23R (G VHH -IL-23R; (SyCyR(IL-23R)) ( Fig. 5a and Supplementary Fig. 1 ). Interestingly, 3xGFP and 2xGFP-mCherry fusion proteins induced proliferation of Ba/F3-SyCyR(IL-23R) cells (Fig. 5b) , whereas single GFP and mCherry or the heterodimeric GFPmCherry fusion protein did not (Fig. 5b) . Half-maximal proliferation was achieved at about 10-20 ng/ml 3xGFP (86 kDa) (Fig. 5c) , which was only slightly lower as compared to Ba/F3-IL-12Rβ1-IL-23R cells stimulated with HIL-23 (56 kDa; 5-10 ng/ml). Thus, the slightly reduced activity cannot be explained through differences in the molar concentrations of the molecules. As expected, 3xGFP and 2xGFP-mCherry fusion proteins but not single GFP induced JAK, STAT3, pERK1/2, and AKT phosphorylation in Ba/F3-SyCyR(IL-23R) cells (Fig. 5d, e) . Also the kinetics of pSTAT3 activation and SOCS3 expression of HIL-23 and 3xGFP were comparable (Figs. 5f and 2f), suggesting that also IL-23R homodimers were not negatively regulated by SOCS3. Surprisingly, only 35 genes were up-or downregulated by at least 1.5-fold after stimulation of Ba/F3-SyCyR(IL-23R) with 3xGFP. However, 34 out of 35 transcripts were also found in the GFPmCherry-group (Ba/F3-SyCyR(IL-23/2 A)) (Fig. 6a ). Among the 35 regulated genes are typical IL-23 target genes, including PIM, SOCS3, and OSM (Fig. 6b, c (Fig. 7a and Supplementary  Fig. 9a ). Janus kinases interact with peptide motifs within the IL-23R localized between amino acid 403-479 and complete or partial deletion results in disabled JAK activity 18 . Accordingly, we created three deletion variants of the IL-23R intracellular domain with disabled JAK activity, ΔJAK-A (Δ403-417), ΔJAK-B (Δ455-479), and ΔJAK-C (Δ403-479) 20 fused to the mCherrynanobody ( Fig. 7a and Supplementary Fig. 9a ). Cell surface expression of these SyCyRs in Ba/F3-gp130 cells was verified by flow cytometry (Supplementary Fig. 9b ). As expected, stimulation of G VHH -IL-23R-ΔSTAT in Ba/F3-gp130 cells with 2xGFP-mCherry resulted in JAK and ERK phosphorylation but defective STAT3 activation (Fig. 7b, c) . Consequently, 3xGFP-induced proliferation of Ba/F3-G VHH -IL-23R-ΔSTAT cells was drastically reduced as compared to Ba/F3-SyCyR(IL-23R) cells (Fig. 7d) . Interestingly, only the assembly of a 2xGFP-mCherry-induced trimeric complex consisting of two G VHH -IL-23R-ΔSTAT receptors and one C VHH -IL-23R-ΔJAK receptor resulted in increased STAT3 trans-phosphorylation and cellular proliferation ( Fig. 7c, e) . Dimerization of G VHH -IL-23R-ΔSTAT with all C VHH -ΔJAK receptors by GFP-mCherry did not induce STAT activation, demonstrating that two biologically active JAKs in G VHH -IL-23R-ΔSTAT were needed for STAT3 trans-phosphorylation. Of note, also stimulation with a 2xmCherry fusion protein and formation of dimeric C VHH -IL-23R-ΔJAK did not result in STAT3 phosphorylation, whereas homodimers of C VHH -IL-23R were biologically active ( Supplementary Fig. 10 ), demonstrating that the C VHH -IL-23R-ΔJAK variants were not biologically active as dimers. Cytokine receptors can be classified into high-affinity binders with longer ICDs and lower-affinity binders with shorter ICDs. Interestingly, high-affinity receptors with STAT-binding sites often heterodimerize with JAK1 or JAK2, whereas low-affinity receptors often pair with TYK2 or JAK3, and minimally contribute to STAT recruitment and activation 21, 22 . Combining the short ICD-and TYK-binding-receptor G VHH -IL-12Rβ1 with C VHH -IL-23R-ΔJAK-B, in Ba/F3-gp130 cell lines did not result in trans-phosphorylation and proliferation (Fig. 8b , c and Supplementary Fig. 11 ), demonstrating that this combination fails to induce receptor activation.
Finally, we asked if the SyCyRs C VHH -IL-23R-ΔJAK-B might be trans-phosphorylated by G VHH -gp130 (SyCyR(IL-6)). We generated a C-terminally truncated gp130 (Δ758) lacking both the STAT and ERK/AKT activation motifs 23 fused to the G VHH (G VHH -gp130-ΔSTAT) ( Fig. 8d and Supplementary Fig. 12 ). Ba/ F3-gp130 cells expressing G VHH -gp130-ΔSTAT displayed no STAT3 phosphorylation after stimulation with 2xGFP-mCherry and 3xGFP (Fig. 8e) . In analogy to the IL-23R-ΔSTAT-SyCyRs, the combined activation of G VHH -gp130-ΔSTAT with C VHH -IL-23R-ΔJAK-B resulted in STAT3 trans-phosphorylation and cellular proliferation (Fig. 8e, f) .
Discussion
Here, we describe the development of a synthetic cytokine receptor system based on nanobodies directed against GFP and mCherry fused to truncated cytokine receptors. Nanobodies are versatile tools widely used in molecular biology, exhibiting highaffinity and antigen specificity. We chose nanobodies against GFP and mCherry because these fluorescent proteins are non-toxic to mammalian cells, will not cause unspecific binding to endogenous receptors and are, therefore, considered as side-effect/background-free 24, 25 . As receptor system, we used heterodimeric and homodimeric cytokine receptor compositions exemplified by IL-23 and IL-6 receptor signaling complexes. IL-23 signals via a heterodimeric receptor complex consisting of IL-12Rβ1 and IL-23R, whereas IL-6 signals via the non-signal-transducing IL-6R and the signal-transducing homodimer of gp130 19 . Both receptor complexes induce signals via receptor-associated Janus kinases that activate STAT, ERK, and AKT pathways 26, 27 . JAKs are constitutive but non-covalently associated with class I and II cytokine receptors, which upon cytokine binding bring together two JAKs to create an active signaling complex. JAK interact with receptor peptide motifs, which are present in the intracellular domain of cytokine receptors. During receptor activation, JAKs switch into the "on''-status by reciprocal phosphorylation and subsequent phosphorylation of receptor-tyrosines and signaling molecules such as STAT3 28 .
The synthetic receptor complex mimicking IL-23-signaling was activated by a heterodimeric synthetic GFP-mCherry ligand but not by single GFP or mCherry or multimeric GFP fusion proteins, whereas the synthetic receptor complex simulating IL-6-signaling was specifically activated by homodimeric synthetic GFP-ligands. Importantly, GFP-mCherry and 3xGFP fusion proteins did not activate cellular responses in cells lacking synthetic cytokine receptors.
A recent report showed that not only the intracellular domains determine the signaling strength but also the mode of extracellular receptor complex assembly 29 . Specifically, a point mutation in EPO was shown to change EPO receptor dimerization, which resulted in reduced STAT1 and STAT3 phosphorylation ) cells were washed three times, starved, and stimulated with GFP-mCherry (100 ng/ml), HIL-23 (25 ng/ml), and HIL-6 (25 ng/ml) for 0-480 min. Stimulation with HIL-23 and HIL-6 were used as control. Cellular lysates were prepared, and equal amounts of total protein (50 μg/lane) were loaded on SDS gels, followed by immunoblotting using specific antibodies for phospho-STAT3 and STAT3, SOCS3, and β-actin. Western blot data show one representative experiment out of three. b Ba/F3-IL-12Rβ1-IL-23R cells were washed three times, starved, and stimulated with HIL-23 (25 ng/ml) for 0-480 min. Stimulation with GFP-mCherry (100 ng/ml) and HIL-6 (25 ng/ml) were used as control. Cellular lysates were prepared, and equal amounts of total protein (50 μg/lane) were loaded on SDS gels, followed by immunoblotting using specific antibodies for phospho-STAT3 and STAT3, SOCS3, and β-actin. compared to GFP-mCherry stimulation, this difference was within expected fluctuations when using cell lines, which have been transduced with different receptor complexes and have been independently selected and cultivated for several weeks. Importantly, pathway analysis of the natural and synthetic IL-23 receptor complexes highlighted that naturally and synthetically induced signal transduction was basically identical. To the best of our knowledge, this is the first study using chimeric receptor complexes, which included a detailed analysis of signal transduction pathways and expression profiles. Importantly, the synthetic receptors appear to be active in vivo, since we demonstrated the activation of G VHH -gp130 by 3xGFP in the liver of mice after hydrodynamic injection. So far, no signaling role of IL-12Rβ1 in the receptor complex apart from activation of a Janus kinase has been assigned 20 . Consistently, using our synthetic receptors, we induced IL-23R homodimeric receptor complexes, as we have recently suggested 30, 31 . Although the general activation of signaling pathways appeared to be similar to IL-23 signaling, gene-array analysis revealed a reduced number of regulated genes when compared to heterodimeric signaling. This phenomenon could be caused by the slightly reduced proliferation observed following SyCyR(IL-23R) signaling when compared to natural IL-23R/IL-12Rβ1 complex. Moreover, reduced affinity or biochemical features of the synthetic ligand may affect SyCyR signaling. This effect might also contribute to the observation, that the natural and synthetic IL-23 receptor activation was different in terms of the absolute number of regulated genes.
The modular nature of the synthetic ligands, with one receptor binding site per GFP or mCherry allows an exact composition of the receptor stoichiometry, which clearly will be interesting for many if not all other cytokine receptors. Moreover, this system will enable the combinatory assembly of uncommon receptor combinations with desirable signaling potentials and capacities. The number of recruited synthetic receptors is only limited by the maximal number of ligands connected in one GFP:mCherry fusion protein or by alternative GFP/mCherry multimerization strategies 32, 33 .
Two recent reports describe surrogate dimeric ligands, which specifically bind and activate natural cytokine receptors supporting our hypothesis that receptor activation might be generally possible by dimeric ligands 34, 35 . For IL-6 and IL-23 signaling, we used homo-and heterodimeric GFP:mCherry fusion proteins, but we were also able to generate homo-and heterotrimeric GFP: mCherry variants. Using these synthetic ligands, we analyzed, if biologically active trimeric receptor complexes could also be functionally assembled among the cytokine receptor family with associated kinases. Tyrosine-receptors and receptors with associated kinases are typically active as dimers 36 to juxtapose and subsequently activate at least two receptor kinases. This implies that these receptor systems naturally did not require a third receptor. To generate trimeric receptor complexes for IL-6 and IL-23-simulations, we deleted the STAT3-binding motifs in the synthetic G VHH -IL-23 and G VHH -gp130 receptors and combined these receptors with JAK-deficient receptors containing STATbinding motifs fused to C VHH . We showed that in these trimeric receptor combinations, STAT3 activation is mediated by transphosphorylation. The formation of a trimeric receptor complex with two JAK-proficient but STAT-deficient receptors and one STAT-binding motif receptor by GFP-GFP-mCherry (2xGFP-mCherry) resulted in STAT3 trans-phosphorylation. Assembly of one JAK-proficient receptor with one STAT-binding motif receptor by a GFP-mCherry fusion did, however, not lead to trans-phosphorylation, confirming that one Janus kinase is not sufficient for receptor activation. Of note, trans-phosphorylation was thus far only described for tyrosine-kinase-receptors of the PDGF and EGF family [37] [38] [39] [40] [41] , in which a kinase-active receptor was able to trans-phosphorylate a second kinase-inactive mutant receptor after receptor dimerization. In these cases, the kinasenegative mutant receptor was able to activate the functional kinase of the other receptor. Here, we describe for the first receptor-chain trans-phosphorylation for cytokine receptors with associated Janus kinases.
In summary, the synthetic cytokine receptor system allows tailor-made activation and analysis of cytokine signaling by recruitment of defined numbers and compositions of receptor chains. Receptor assembly is determined by the number and sequence of GFP-mCherry units in the ligand fusion proteins. This system simulates signal transduction without relevant background activation that has been described previously with chimeric receptor systems 6 . The lack of toxicity of fluorescent proteins in vitro and in vivo allows a widespread area of potential applications for studying cell-type specific receptor activation by synthetic ligand application in transgenic mice. Importantly, our system is easily on/off-switchable, because signal activation can be rapidly inhibited by application of soluble nanobody-fusion proteins directed against the synthetic GFP:mCherry ligands and will open up therapeutic regimes involving non-physiological targets during immunotherapy.
Methods
Cells and reagents. CHO-K1 (ACC-110) cells were from Leibniz Institute DSMZGerman Collection of Microorganisms and Cell Cultures (Braunschweig, Germany). U4C cells were kindly provided by Heike Hermanns (University Würzburg, Fig. 4 SyCyRs for IL-6 (SyCyR(IL-6)) simulate IL-6/IL-11-induced signal transduction. a Schematic illustration of IL-6 SyCyR and GFP-GFP. G VHH -gp130: G VHH fused to 13 aa of the ECD, TMD, and ICD of gp130. b JAK and TYK activation in Ba/F3-SyCyR(IL-6) cells stimulated with supernatants containing 100 ng/ml of indicated synthetic ligands or HIL-6 (100 ng/ml) for 20 min. Equal amounts of total protein (50 μg/lane) were analyzed for phospho-JAK2/ TYK2/JAK1 and JAK2/TYK2/JAK1. Western blot data show one representative experiment out of three. c STAT3 and ERK1/2 activation in Ba/F3-SyCyR (IL-6) cells stimulated with 4% conditioned supernatant containing mCherry, 2xmCherry or conditioned supernatants containing 100 ng/ml of indicated synthetic ligands for 60 min. Stimulation with HIL-6 (10 ng/ml) for 15 min was used as control. Equal amounts of total protein (50 μg/lane) were analyzed for phospho-STAT3/ERK1/2 and STAT3/ERK1/2. One representative experiment out of two is shown. d Proliferation of Ba/F3-SyCyR(IL-6) and Ba/F3-gp130 cells with 3xGFP and HIL-6 cultured in the presence of ligands (0.1 to 1600 ng/ml). One representative experiment out of five is shown. Results are mean ± s.d. of three replicates. e Ba/F3-SyCyR(IL-6) cells were stimulated with 3xGFP (100 ng/ml) and HIL-6 (25 ng/ml) for 0-480 min. Total protein (50 μg/lane) were analyzed for phospho-STAT3 and STAT3, SOCS3, and β-actin. Western blot data show one representative experiment out of three. f Western blot of mouse liver lysates and mouse serum prepared 24 h following hydrodynamic transfection of PBS, pcDNA3.1-3xGFP (1.28 µg) and/or pcDNA3.1-G VHH -gp130 (2.3 µg) plasmid DNA. Total proteins (50 μg/lane) were analyzed for phospho-STAT3, STAT3, GFP, and γ-tubulin. Serum volumes from 0.25-1 µl were analyzed for GFP; n = 3 animals/group. g Ratio of relative density of pSTAT3 and STAT3 liver expression as determined in f; Results are mean ± s.e.m. of three animals/group. Significance of difference (one-way ANOVA): *p < 0.05. h qRT-PCR of Saa1 mRNA 24 h after hydrodynamic transfection of 1.28 µg pcDNA3.1-3xGFP and/or 2.3 µg pcDNA3.1-G VHH -gp130 plasmid and normalized using the housekeeper mRNA Gapdh and the ΔΔCT method; Results are mean ± s.e.m. of six animals/group. Significance of difference (one-way ANOVA): *p < 0.05 Germany). Murine Ba/F3-gp130 cells transduced with human gp130 were provided by Immunex (Seattle, WA, USA) 42 . The packaging cell line Phoenix-Eco was obtained from Ursula Klingmüller (DKFZ, Heidelberg, Germany) 43 . Ba/F3-gp130 cells with murine IL-12Rβ1 and murine IL-23R have been described previously 18 . All cell lines were grown in Dulbecco's modified Eagle medium (DMEM) highglucose culture medium (GIBCO®, Life Technologies, Darmstadt, Germany) supplemented with 10% fetal calf serum (GIBCO®, Life Technologies, Darmstadt, Germany), 60 mg/l penicillin and 100 mg/l streptomycin (Genaxxon Bioscience GmbH, Ulm, Germany) at 37°C with 5% CO 2 in a water saturated atmosphere. Ba/ F3-gp130 cells were maintained in the presence of Hyper-IL-6 (HIL-6), a fusion protein of IL-6 and the soluble IL-6R, which mimics IL-6 trans-signaling 44 . Either recombinant protein (10 ng/ml) or 0.2% (10 ng/ml) of conditioned cell culture medium from a stable CHO-K1 clone secreting Hyper-IL-6 (stock solution approx. 5 µg/ml as determined by ELISA) were used to supplement the growth medium. Ba/F3-IL-12Rβ1-IL-23R cells expressing murine IL-23R and murine IL-12Rβ1 were stimulated with 0.2% (10 ng/ml) of conditioned cell culture medium from a stable CHO-K1 clone secreting murine Hyper-IL-23 (HIL-23) in a concentration of approx. 5 µg/ml, as determined by ELISA 18 (ERK1/2) (1:1000, cat. #9102), phospho-AKT (Ser473) (D9E) (1:000, cat. #4060), AKT (1:1000, cat. #9272S), phospho-JAK1 (Tyr1022/1023) (1:000, cat. #3331), JAK1 (6G4) (1:1000, cat. #3344S), phospho-JAK2 (Tyr1007/1008) (1:1000, cat. #3771), JAK2 (D2E12) (1:000, cat. #3230), phospho-TYK2 (Tyr1054/1055) (1:000, cat. #9321), TYK2 (1:000, cat. #9312), GFP (4B10) (1:000, cat. #2955) and myc (71D10), (1:1000 for western blotting and 1. Construction SyCyRs and synthetic ligands. pcDNA3.1-G VHH -IL-23R expression vector was generated by fusion of coding sequences for human IL-11R signal peptide (Q14626, aa 1-24) followed by sequences for myc tag (EQKLISEEDL), GFP-nanobody (G VHH ) 15 and murine IL-23R (Q8K4B4) comprising amino acids A358 to K644 representing 17 aa of the extracellular domain, the transmembrane domain and the cytoplasmic part of the receptor. The cDNA coding for G VHH -IL-12Rβ1 was generated by insertion of cDNA coding for murine IL-12Rβ1 (Q60837, aa A551-A738, representing 15 aa of the extracellular domain, the transmembrane domain and the cytoplasmic part of the receptor), which was amplified by PCR from p409-IL-12Rβ1 18 , into expression vector pcDNA3.1-G VHH -IL-23R, where the coding sequence for IL-23R was removed. pcDNA3.1-C VHH -IL-23R expression vector was generated by fusion of coding sequences for human IL-11R signal peptide (Q14626, aa 1-24) followed by sequences for Flag-tag (DYKDDDDK), mCherry-nanobody (C VHH ) 14 ΔSTAT (Δ503) was amplified by PCR from pcDNA3.1-IL-23R-ΔSTAT (Δ503) 18 and inserted into pcDNA3.1-G VHH -IL-23R, where the sequence for IL-23R was removed. Accordingly, cDNAs coding for ΔJAK-A (IL-23R-Δ403-417), ΔJAK-B (IL-23R-Δ455-479), and ΔJAK-C (IL-23R-Δ403-479) were amplified by PCR from p409-IL-23R-Δ403-417, -IL-23R-Δ455-479, and -IL-23R-Δ403-479 20 containing 16 aa of the extracellular domain, the transmembrane domain and the shortened cytoplasmic part of the receptor and inserted into pcDNA3.1-C VHH -IL-23R, where the coding sequence for IL-23R was removed. p409-gp130 (chemically synthesized by GeneArt, Thermo Fisher Scientific, Waltham, MA, USA) was digested by EcoRI, NotI and ligated in pcDNA3.1-G VHH -IL-23R, which was digested by the same enzymes to generate pcDNA3.1-G VHH -gp130 containing 16 aa of the extracellular domain, the transmembrane domain and the intracellular domain of the human receptor. cDNA coding for gp130-ΔSTAT was amplified by PCR (aa 1-758) and ligated to the same vector mentioned before. The expression cassette for 3xGFP was obtained from pmEGFP-13 (Addgene, Cambridge, MA, USA) 46 and inserted into pcDNA3.1 expression vector containing the IL-11R signal peptide and an Nterminal Flag-tag (DYKDDDDK). To generate pcDNA3.1-2xGFP-mCherry, one GFP from pcDNA3.1-3xGFP was removed and replaced with mCherry from pcDNA3.1-mCherry. To create single GFP, the cDNA coding for GFP was amplified by PCR from pcDNA3.1-2xGFP-mCherry and inserted into the pcDNA3.1 expression vector. To create pcDNA3.1-GFP-mCherry, cDNA coding for mCherry was inserted into pcDNA3.1-GFP. For retroviral transduction of Ba/ F3-gp130 cells two retroviral plasmids with different resistance genes, pMOWSpuro 43 coding for puromycin resistance and pMOWS-hygro 4 for hygromycin B resistance, have been used. Expression cassettes coding for G VHH -IL-23R, C VHH -
, and G VHH -gp130 were inserted into pMOWS-puro, whereas those for G VHH -IL-12Rβ1, G VHH -IL-23R-ΔSTAT (Δ503) and G VHH -gp130-ΔSTAT were inserted into pMOWS-hygro. All generated expression plasmids have been verified by sequencing.
Transfection and selection of cells. Transfection of U4C and CHO-K1 cells with indicated plasmids was performed using TurboFect™ (Thermo Fisher Scientific, Waltham, MA, USA). Ba/F3-gp130 cells were retrovirally transduced with the pMOWS expression plasmids coding for the various synthetic receptor variants 18 . Transduced cells were grown in standard DMEM medium as described above supplemented with 10 ng/ml HIL-6. Selection of transduced Ba/F3 cells was performed with puromycin (1.5 µg/ml) or hygromycin B (1 mg/ml) (Carl Roth, Karlsruhe, Germany) or both for at least 2 weeks. Afterwards, HIL-6 was washed away and the generated Ba/F3-gp130 cell lines were selected for GFP:mCherrydependent growth and analyzed for receptor cell surface expression. Stable transfected CHO-K1 cells secreting GFP:mCherry proteins were selected with 1.125 mg/ ml G-418 sulfate (Genaxxon, Biosciences, Ulm, Germany). High-expressing cell clones were identified by western blotting.
Expression and purification of G VHH -C VHH from E.coli. The cDNA coding for the bispecific antibody G VHH -C VHH was generated and subcloned in pet23a. The resulting bispecific antibody sequence was flanked by an N-terminal PelB leader sequence for periplasmic expression and a 3' hexahistidine sequence for purification. Proteins were expressed in the E.coli strain BL21-Rosetta. Bacteria were incubated in 2 l LB-media containing ampicillin 1:1000 (100 µg/ml) and chloramphenicol 1:1000 (34 µg/ml) at 37°C, until optical density reached 0.6-0.9. Then 1 mM IPTG was added. Bacteria were harvested by centrifugation (5000 × g, 30 min, 4°C) 4 h after IPTG induction. A cOmplete protease inhibitor tablet (Roche, Mannheim, Germany) was added and supernatant was filtered through a 0.45 µm bottle top filter. Proteins were purified via IMAC chromatography and eluted with 500 mM imidazole. Imaging Instruments GmbH, Göttingen, Germany) were used for signal detection. For re-probing with another primary antibody, the membranes were stripped in 62.5 mM Tris-HCl (Carl Roth, Karlsruhe, Germany) pH 6.8, 2% SDS (Carl Roth, Karlsruhe, Germany) and 0.1% β-mercaptoethanol (Sigma Aldrich, Munich, Germany) for 30 min at 60°C and blocked again. The band intensities of the western blots (Fig. 4f) were quantified using ImageJ software. Uncropped images of western blots are presented in Supplementary  Fig. 13 . Microarray analysis. Ba/F3-gp130 cells were grown in DMEM high-glucose culture medium supplemented with 10% fetal calf serum (GIBCO®, Life Technologies, Darmstadt, Germany), 60 mg/l penicillin and 100 mg/l streptomycin (Genaxxon Bioscience GmbH, Ulm, Germany) at 37°C with 5% CO 2 in a water saturated atmosphere. In all, 10 ng/ml of conditioned cell culture medium from a stable CHO-K1 clone secreting Hyper-IL-6 (stock solution approx. 5 µg/ml as determined by ELISA) were used to supplement the growth medium. Ba/F3-gp130 cells were 
